Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




DNA-Powered Test Accurately Detects E. Coli Lookalike Bacteria

By LabMedica International staff writers
Posted on 28 Oct 2025

Accurately diagnosing bacterial infections remains a major clinical challenge, particularly when genetically similar species mimic one another. More...

Such is the case with Escherichia marmotae, a bacterium often mistaken for E. coli in lab tests, leading to misdiagnosis and use of broad-spectrum antibiotics. Now, a new DNA-powered test is capable of distinguishing between the two species with precision, improving diagnosis and targeted treatment.

The test, developed by researchers at the Wayne State University School of Medicine (Detroit, MI, USA), is a polymerase chain reaction (PCR) assay that identifies unique biomarker peaks, accurately detecting E. marmotae without cross-reacting with E. coli or related bacteria. Unlike earlier methods that relied on overlapping E. coli markers, the new test is based on a 10% divergence in genome sequences and distinct differences in protein spectra between the two species. This enables reliable identification of E. marmotae in clinical isolates for the first time in North America.

The research, published in Frontiers in Microbiology, highlights how previous diagnostic limitations led to the routine use of broad-spectrum antibiotics when E. marmotae was misidentified as E. coli. The new methods can not only improve diagnosis but also enable tracking of E. marmotae infections across regions.

“The medical response to a bacterial infection is often application of broad-spectrum antibiotics, which is the usual response when E. marmotae is mistaken for E. coli,” said lead researcher Pelumi Oladipo. “If species-specific methods for targeting bacteria in such infections can be developed, then identifying E. marmotae with our newly developed methods could be critical to applying the most effective therapy.”

Related Links:
Wayne State University School of Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.